Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders

Trial ID or NCT#

NCT00704106

Status

not recruiting iconNOT RECRUITING

Purpose

We propose a largely retrospective study with short-term prospective follow-up in a subgroup of patients who have not yet been treated with 48 weeks of entecavir following partial response to adefovir. The aim of the study is to describe sequential virologic response to adefovir and entecavir.

Official Title

HBV Viral Suppression by Entecavir in Adefovir Partial Responders

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Hepatologist, Transplant hepatologist
Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Epidemiology and Population Health

Contact us to find out if this trial is right for you.

Contact

Mindie H. Nguyen, MD
650-498-7878

View on ClinicalTrials.gov